Rhodamine derivatives for photodynamic diagnosis and treatment
US8409564B2 · kind B2 · utility
2Cited by
8References
2Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Oct 21, 2004 |
| Grant date | Apr 2, 2013 |
| Priority date | — |
| Expiry date | Nov 5, 2025 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D311/82
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to the use of the photoactivable derivatives for the photodynamic treatment for the selective destruction and/or inactivation of immunologically reactive cells without affecting the normal cells and without causing systemic toxicity for the patient, wherein appropriate intracellular levels of said derivatives are achieved and irradiation of a suitable wavelength and intensity is applied.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.